Navigation Links
Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry
Date:6/14/2011

NEW YORK, June 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

http://www.reportlinker.com/p0553601/Pharmaceutical-Key-Trends-2011-Overview---Key-strategic-trends-in-the-pharmaceutical-industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Managed_c

Introduction

A number of factors have and will continue to impact pharmaceutical sales and profits going forward. As a result of rising healthcare costs, healthcare budgets are being stretched.

Healthcare payers are also feeling the impact of the global economic downturn.

As a result, payers are introducing a number of cost-containment strategies as well as tougher regulatory measures

Features and benefits

* An overview of drivers of rising healthcare costs

* Review the impact of the global economic downturn on the healthcare and the pharmaceutical industry

* Assess the growing cost-containment and regulatory pressures facing pharma

* An overview of the impact of the patent expiries on pharma together with the industry's responses

Highlights

Aging populations, the growing prevalence of chronic disease, greater use of expensive treatments, and expanding public healthcare coverage are stretching existing healthcare resources. As a result of rising unemployment, healthcare payers are also feeling the impact of the global economic downturn through reduced funding via taxation.

In response, payers are introducing a number of cost-containment strategies, such as reducing healthcare budgets and implementing pricing and reimbursement cuts, as well as bolstering generic uptake. These measures, together with the increasingly tough regulatory environment, all have a negative impact on the pharmaceutical industry.

Branded pharmaceutical companies are set to lose approximately $100bn in sales due to the patent cliff and the resultant generic erosion of branded sales during 2010–15 in the seven major markets, while the industry is also feeling the effects of the recent global economic downturn both directly and indirectly.

Your key questions answered

* Evaluate factors driving healthcare costs in the developed and emerging markets, and how the economic downturn has impacted the healthcare landscape

* Gain insight into the impact that the patent cliff as well as growing use of biosimilars will have on branded pharma sales out to 2015

* Review the growing cost-containment and regulatory measures facing pharma, as well as the industry's response to grow profitability going forward

Executive Summary

Strategic scoping and focus

Key findings

DRIVERS OF RISING HEALTHCARE COSTS

Demographic trends in the major developed and emerging markets

Aging patient populations

Growing prevalence of chronic diseases

Greater use of expensive treatments – pharmaceutical expenditure is increasing in all markets

Expanding pubic healthcare coverage

IMPACT OF THE GLOBAL ECONOMIC DOWNTURN ON HEALTHCARE AND PHARMA

Impact of the economic downturn on both developed and emerging markets

Growing uninsured population – US patients are less able to cover the costs of healthcare, including pharmaceuticals

Government strategies to cut the budget deficit target healthcare and pharmaceutical expenditure

COST-CONTAINMENT AND REGULATORY PRESSURES

Government strategies to contain healthcare and pharma costs

Healthcare spending has slowed in several markets as governments bring in austerity measures

Pricing and reimbursement cuts were key elements included in austerity measures in many developed markets

Regulatory changes have a largely negative impact on pharma

Healthcare systems globally are converging toward a similar model

Driving generic uptake will create further savings

THE PATENT CLIFF

The patent cliff represents a major resistor to branded pharma growth

Branded pharma set to lose $82bn due to the patent cliff

Biosimilar uptake is set to accelerate

PHARMA'S STRATEGIC RESPONSES TO DRIVE PROFITABILITY

Pharma innovates, diversifies, and contains cost in order to grow profits

Pharma's strategic responses to drive sales and profitability

Innovation – pharma sharpens its focus on secondary care indications through high value biologic therapies

Diversification – growth in global markets will more than offset sales decline in the US

Cost-cutting – pharma cuts cost to increase margins

The impact of pharma's strategic responses on forecast sales during 2010–15

BIBLIOGRAPHY

Publications and online articles

Datamonitor reports and products

APPENDIX

Exchange rates used in this report

To order this report:

Managed care Industry: Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

Managed care Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries
2. Reportlinker Adds Global Electrophysiology Mapping and Ablation Devices Industry
3. Reportlinker Adds Middle East And Africa Neurology Devices Market Outlook to 2017
4. Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017
5. Reportlinker Adds Middle East and Africa Dental Devices Market Outlook to 2017
6. Reportlinker Adds Asia-Pacific Markets for Patient Monitoring Devices 2011
7. Reportlinker Adds European Markets for Hearing Aids and Audiology Devices 2011
8. Reportlinker Adds Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Reportlinker Adds Middle East and Africa ENT Devices Market Outlook to 2017
10. Reportlinker Adds China Medical Devices Industry - A Market Snapshot and Key Company Profiles
11. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)... -- Guerbet announced today that it has been named a ... One of 12 suppliers to receive the ... of Premier members through exceptional local customer service and ... lower costs. "We ... customer service from Premier," says Massimo Carrara , ...
Breaking Medicine Technology:
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
Breaking Medicine News(10 mins):